Lamivudine and adefovir resistance in children and young adults with chronic hepatitis B
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, vol.14, no.3, 2010 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 14 Issue: 3
- Publication Date: 2010
- Doi Number: 10.1016/j.ijid.2009.04.002
- Journal Name: INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Keywords: Lamivudine, Adefovir, Resistance, Hepatitis B
- Dokuz Eylül University Affiliated: No
Abstract
Objective: Long-term lamivudine (LAM) and adefovir (ADV) treatment has been found to induce the emergence of drug-resistant hepatitis B virus (HBV) in a significant number of patients with chronic hepatitis B (CHB) infection. The aim of our study was to evaluate the LAM and ADV mutations detected in our patient group.